GPX4 and hepatocellular carcinoma: Here, we found that HBV suppressed sorafenib-induced ferroptosis in HCC cells through the SRSF2/PCLAF tv1 pathway by lowering intracellular Fe2+ levels and boosting GPX4 expression.